Meanwhile, Vertex is in the process of rolling out its gene-editing therapy Casgevy, the first CRISPR therapy ever approved and one that serves as a functional cure for two rare blood disorders. The ...
Learn why it's crucial to review your Medicare Part D ANOC letter this year, as major changes in 2025 could impact your premiums, coverage, and out-of-pocket costs.
I wanted to get diagnosed as soon as possible, to start exploring options for treatment, medication. So… I did nothing for four years. Why? Because I have ADHD. Asking someone who thinks they have ...